Abryl Formulations Private Limited

Pharmaceutical company that acquires and sells drugs in Ukraine, also deals with healthcare and medicinal goods.

2006 | Bathinda, Punjab (India) | Active
Last Updated:

Abryl Formulations Profile

Key Indicators

  • Authorised Capital ₹ 0.90 M
  • Paid Up Capital ₹ 0.90 M
  • Company Age 18 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -17.25%
  • Profit Growth 5.48%
  • Ebitda -26.36%
  • Net Worth 27.96%
  • Total Assets -9.84%

About Abryl Formulations

Abryl Formulations Private Limited (AFPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 23 August 2006 and has a history of 18 years and six months. Its registered office is in Bathinda, Punjab, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.

Neerja Singla and Aditya Singla serve as directors at the Company.

Company Details

  • Location

    Bathinda, Punjab, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    abryl.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239PB2006FTC030567

  • Company No.

    030567

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    23 Aug 2006

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Pharma

Who are the key members and board of directors at Abryl Formulations?

Board Members (2)

NameDesignationAppointment DateStatus
Neerja Singla Country flag representing In Director 23-Aug-2006Current
Aditya Singla Director 20-Aug-2024Current

Financial Performance of Abryl Formulations.

Abryl Formulations Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.25% decrease. The company also saw a slight improvement in profitability, with a 5.48% increase in profit. The company's net worth Soared by an impressive increase of 27.96%.

Abryl Formulations revenue growth over time
Abryl Formulations profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-17.25%
Revenue from Operations
-19.11%
Total Assets
-9.84%
Profit or Loss
5.48%
Net Worth
27.96%
EBITDA
-26.36%

What is the Ownership and Shareholding Structure of Abryl Formulations?

In 2019, Abryl Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Abryl Formulations?

Unlock and access historical data on people associated with Abryl Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Abryl Formulations Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Abryl Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abryl Formulations's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Abryl Formulations

Recent activity within the organization

  • Annual General Meeting

    Abryl Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Aditya Singla was appointed as a Director was appointed as a Director on 20 Aug 2024 & has been associated with this company since 6 months 15 days .

  • Balance Sheet

    Abryl Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.

  • Director Appointment

    Neerja Singla was appointed as a Director was appointed as a Director on 23 Aug 2006 & has been associated with this company since 18 years 6 months .

  • Company Incorporation

    Abryl Formulations Private Limited was registered on 23 Aug 2006 with Roc Chandigarh & aged 18 years 6 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Abryl Formulations Private Limited?

    Abryl Formulations Private Limited was incorporated on 23 Aug 2006.

  • What is authorized share capital and paid-up capital of Abryl Formulations Private Limited?

    The authorized share capital of Abryl Formulations Private Limited is ₹ 0.90 M and paid-up capital is ₹ 0.90 M.

  • Who are the current board members & directors of Abryl Formulations Private Limited?

    Currently 2 directors are associated with Abryl Formulations Private Limited.

    • Neerja Singla
    • Aditya Singla

  • What is the registered address of Abryl Formulations Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Abryl Formulations Private Limited is 17406A, Street No. 3 Minocha Colony India, Bathinda, Punjab, 151001.

  • What is the corporate identification number (CIN) and company number of Abryl Formulations Private Limited?

    The corporate identification number (CIN) of Abryl Formulations Private Limited is U24239PB2006FTC030567 and the company number is 030567 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Abryl Formulations Private Limited?

    The Official website of Abryl Formulations Private Limited is https://www.abryl.in

  • What has been the recent revenue trend for Abryl Formulations Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Abryl Formulations Private Limited has fallen by -17.25%.

  • What change has been observed in the net worth of Abryl Formulations Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Abryl Formulations Private Limited has experienced an upsurge of 27.96%.

  • When was the last Balance Sheet of Abryl Formulations Private Limited filed with the ROC?

    The most recent Balance Sheet for Abryl Formulations Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development